Organisation
Department of Pharmaceutics
Department
Current researchers
41 - 50 of 120 results
- Milan Decorte (Member)
- Dieter Deforce (Member)
- Demi Defreyne (Member)
- Jo Demeester (Member)
- Phaedra Denduyver (Member)
- Rachel Dennis (Member)
- Koen Deserranno (Member)
- Maarten Dhaenens (Member)
- Mike Dobbelaere (Member)
- Thomas Ehouarne (Member)
Projects
41 - 50 of 375
- Market oriented validation of bivalent ligands: towards an improved treatment for multiple myelomaFrom1 Feb 2023 → Today
- BOF ZAP photonics for advanced drug deliveryFrom1 Feb 2023 → TodayFunding: BOF - ZAP BOF mandates
- A translational cancer vaccination approach based on co-delivery of tumor antigen and Toll-like receptor agonistsFrom1 Jan 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Flanders BioImaging: Leading Imaging Application Integrated Service and Enablement (FBI-LIAISE)From1 Jan 2023 → TodayFunding: FWO International research infrastructure (IRI)
- BOF-ZAP professorship biopharamaceutical technologyFrom1 Jan 2023 → TodayFunding: BOF - ZAP BOF mandates
- Laser-induced nanobubbles for advanced therapies in the eye.From1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- MITACS: Multivalent Immune TArgeting synthetic Chimeric therapeuticS.From1 Jan 2023 → TodayFunding: BOF - iBOF
- PolySAMP - polymeric sampler for metabolomicsFrom16 Dec 2022 → TodayFunding: IOF - technology validation in lab
- Evaluation of cellular dynamics using automated widefield imagingFrom15 Dec 2022 → TodayFunding: BOF - scientific equipment program
- Continuous linear powder blender for processing of pharmaceuticalsFrom15 Dec 2022 → TodayFunding: BOF - scientific equipment program
Publications
1 - 10 of 1924
- Tailored design of sugar-modified a-GalCer analogues for Th1-polarized immune responses(2018)
Authors: Serge Van Calenbergh
Pages: 42 - 42 - Structural basis for the recognition of C20:2-U+03B1GalCer by the invariant natural killer T-cell receptor-like antibody L363(2012)
Authors: Esther Dawen Yu, Enrico Girardi, Jing Wang, Thien-Thi Mac Mac, Karl OA Yu, Serge Van Calenbergh, Steven A Porcelli, Dirk M Zajonc
Pages: 1269 - 1278 - Common genetic determinants of lung function, subclinical atherosclerosis and risk of coronary artery disease(2014)
Authors: Maria Sabater-Lleal, Aners Mälarstig, Lasse Folkersen, María Soler Artigas, Damiano Baldassarre, Maryam Kavousi, Peter Almgren, Fabrizio Veglia, Guy Brusselle, Albert Hofman, et al.
- Outpatient Pharmacotherapy(2008)
Authors: Guy Brusselle
Pages: 331 - 349 - Properties of the COPD assessment test in a cross-sectional European study(2011)
Authors: PW Jones, Guy Brusselle, RW Dal Negro, M Ferrer, P Kardos, ML Levye, T Perez, JJ Soler Cataluña, T van der Molen, L Adamek, et al.
Pages: 29 - 35 - Mechanistic links between COPD and lung cancer: a role of microRNA let-7?(2014)
Authors: Jae Il Shin, Guy Brusselle
Pages: 70 - 70 - Effect of a 3-month low-dose azithromycin intervention for COPD exacerbations requiring hospitalization on subsequent respiratory events and mortality : the BACE trial(2019)Volume: 199
Authors: W Janssens, K Vermeersch, T Troosters, Guy Brusselle
Number of pages: 1 - Disease-modifying anti-asthmatic drugs(2022)
Authors: Marek Lommatzsch, Guy Brusselle, G. Walter Canonica, David J. Jackson, Parameswaran Nair, Roland Buhl, Johann Christian Virchow
Pages: 1664 - 1668 - I have taken my umbrella, so of course it does not rain(2012)
Authors: DS Postma, Guy Brusselle, A Bush, JW Holloway
Pages: 88 - 89 - Blood eosinophils and smoking history affect outcome with high dose N-acetylcysteine treatment in COPD(2017)Volume: 50
Authors: Alberto Papi, Guy Brusselle, Francesco Sergio, Marco Pannacci, Jinping Zheng, Gerard Criner
Number of pages: 1